|
| |
DOR BioPharmaDOR BioPharma, Inc. is a biopharmaceutical company addressing life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biomedical countermeasures. Our lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD), a common serious complication of bone marrow transplantation for cancer, as well as other GI disorders characterized by severe inflammation. We plan to file a new drug application (NDA) with the FDA for orBec® for the treatment of gastrointestinal GVHD in the July – August timeframe of 2006
Through our BioDefense Division, we are developing biomedical countermeasures pursuant to the paradigm established by the recently enacted Project BioShield Act of 2004. Our biodefense products in development are bioengineered vaccines designed to protect against the deadly effects of ricin toxin and botulinum toxin, both of which are considered serious bioterrorism threats. Our ricin toxin vaccine, RiVaxTM, has successfully completed a Phase I clinical trial in normal volunteers. We have also initiated a botulinum toxin therapeutic development program based on rational drug design.
| Contact Details: |
| 1101 Brickell Avenue Suite 701 South |
| Miami |
| Florida |
| 33131 |
| United States of America |
| Tel: | 786-425-3848 |
| Fax: | 786-425-3853 |
| Email: | info@dorbiopharma.com |
| WWW: | www.dorbiopharma.com/
|
|
Loading...
|
Recent Publications by DOR BioPharma: |  |
Molecular basis for improved anthrax vaccines.
The current vaccine for anthrax has been licensed since 1970 and was... | 28th September, 2005
| DOR BioPharma, Inc., 1691 Michigan Avenue, Suite 435, Miami, FL 33139,
| Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21.
DOI Direct Link |
Press Releases on DOR BioPharma:
|
 |
| Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines |
20th November, 2009 |
Soligenix, Inc. |
PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company,
|
| Soligenix Reports Third Quarter 2009 Financial Results |
13th November, 2009 |
Soligenix, Inc. |
-- The granting of Orphan Drug Designation by the FDA's Office of Orphan
Products Development for oral BDP (beclomethasone 17,21-dipropionate, or
orBec®) for the treatment
|
| Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends |
10th November, 2009 |
Reportlinker |
-- Outlook for the injectable drug delivery technology
Who should buy this report?
-- Stakeholders in the injectable drug delivery market
-- Companies interested in understanding
|
| Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook |
10th November, 2009 |
Reportlinker |
-- Profiles of key emerging drug delivery technologies and profiles of
leading companies, by type of technology
Who Should Buy This Report:
-- Companies interested in understanding
|
| Soligenix to Present at 8th Annual BIO Investor Forum |
27th October, 2009 |
Soligenix, Inc. |
PRINCETON, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Soligenix, Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company,
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 371 times since April 2007, the link to the organisation's website has been followed 58 times Recent Search Terms used to find this page: dor biopharma miami | DOR BioPharma | . Search for more companies in Miami Search for more companies in Florida This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for DOR BioPharma |
